International News

GlaxoSmithKline Withdraws Application Seeking Patent for Antiretroviral Drug Combivir in India

From Henry J. Kaiser Family Foundation

August 23, 2006

GlaxoSmithKline withdrew a patent application in India for its twice-daily antiretroviral Combivir, Bloomberg/Philadelphia Inquirer reports. Although GSK did not give details as to why the application was withdrawn, N.Y. Sanglikar, spokesperson for the company's India unit, said in a telephone interview that it was withdrawn "voluntarily." Medecins Sans Frontieres in March said that groups in the country opposed the application because the drug was not new. The drug also would become more expensive because pharmaceutical companies that produce generic versions would have had to pay a "reasonable royalty" to the company, according to MSF (Bloomberg/Philadelphia Inquirer, 8/22).

Back to other news for August 23, 2006

Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2006 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Initial Results of HIV Vaccine Trial in China Show It Is Safe, Effective, Government Agency Says

Opponents of Male Circumcision Urge International Organizations Not to Back Procedure as HIV Prevention Strategy

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.

More HIV News

10 Questions to Ask Yourself Before You Begin HIV Treatment

Getting to Undetectable: People Living With HIV Share Their Stories

HIV Management Today: Mental Health & HIV, the Uncharted Territory

Let's Talk About the HIV Cure News: A Blog Entry by Warren Tong

Get TheBody.com in the Palm of Your Hand

More >>

New! TheBody.com App

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

U.S. ASO Finder

The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.